Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology

Detalhes bibliográficos
Autor(a) principal: Leon,Rogéria M.
Data de Publicação: 2016
Outros Autores: Ranzi,Alana D., Fardin,Graziele S., Keitel,Elizete, Brackmann,Rosicler Luzia, Prolla,João Carlos, Bica,Claudia G.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000100025
Resumo: ABSTRACT Introduction: Human papillomavirus (HPV) is the main cause of cervical cancer, and immunosuppression is recognized as a risk factor for HPV infection and its persistence. After renal transplantation, immunosuppressive agents are used to prevent rejection, but predispose recipients to chronic infections and malignancies. Objective: This study aimed to verify, based on urinary cytology (UC), the prevalence of HPV in immunosuppressed kidney transplant patients. Material and method: In this cross-sectional study, the population was composed of kidney transplant patients that had undergone routine UC from August 2012 to August 2014. Results: There were 2,305 urine cytopathological tests. Thirteen patients with presence of koilocytes in such examination were observed. Therefore, the relative frequency of patients with HPV detected in urine was 0.56%. In the interval until the first post-transplant year, 10 (76.92%) patients presented koilocytes (p < 0.0001) in the UC. The dosages of immunosuppressive agents until the first post-transplant consultation, which showed correlation with the period between transplantation and the first UC test with the presence of koilocytes (p < 0.0001), were prednisone 10.5-20 mg/day, mycophenolate sodium 901-1,440 mg/day, and tacrolimus 4.5-12 mg/day. Conclusion: This study showed immunosuppression as an important risk factor for infection by HPV or its reactivation. Screening UC tests after transplantation may evidence HPV infection.
id SBP-1_9a3da516145f5b3f6526cd757813228d
oai_identifier_str oai:scielo:S1676-24442016000100025
network_acronym_str SBP-1
network_name_str Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
repository_id_str
spelling Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytologyimmunosuppressionrisk factorskidney transplantationpapillomavirus infectionsABSTRACT Introduction: Human papillomavirus (HPV) is the main cause of cervical cancer, and immunosuppression is recognized as a risk factor for HPV infection and its persistence. After renal transplantation, immunosuppressive agents are used to prevent rejection, but predispose recipients to chronic infections and malignancies. Objective: This study aimed to verify, based on urinary cytology (UC), the prevalence of HPV in immunosuppressed kidney transplant patients. Material and method: In this cross-sectional study, the population was composed of kidney transplant patients that had undergone routine UC from August 2012 to August 2014. Results: There were 2,305 urine cytopathological tests. Thirteen patients with presence of koilocytes in such examination were observed. Therefore, the relative frequency of patients with HPV detected in urine was 0.56%. In the interval until the first post-transplant year, 10 (76.92%) patients presented koilocytes (p < 0.0001) in the UC. The dosages of immunosuppressive agents until the first post-transplant consultation, which showed correlation with the period between transplantation and the first UC test with the presence of koilocytes (p < 0.0001), were prednisone 10.5-20 mg/day, mycophenolate sodium 901-1,440 mg/day, and tacrolimus 4.5-12 mg/day. Conclusion: This study showed immunosuppression as an important risk factor for infection by HPV or its reactivation. Screening UC tests after transplantation may evidence HPV infection.Sociedade Brasileira de Patologia Clínica2016-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000100025Jornal Brasileiro de Patologia e Medicina Laboratorial v.52 n.1 2016reponame:Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)instname:Sociedade Brasileira de Patologia (SBP)instacron:SBP10.5935/1676-2444.20160009info:eu-repo/semantics/openAccessLeon,Rogéria M.Ranzi,Alana D.Fardin,Graziele S.Keitel,ElizeteBrackmann,Rosicler LuziaProlla,João CarlosBica,Claudia G.eng2016-03-02T00:00:00Zoai:scielo:S1676-24442016000100025Revistahttp://www.scielo.br/jbpmlhttps://old.scielo.br/oai/scielo-oai.php||jbpml@sbpc.org.br1678-47741676-2444opendoar:2016-03-02T00:00Jornal Brasileiro de Patologia e Medicina Laboratorial (Online) - Sociedade Brasileira de Patologia (SBP)false
dc.title.none.fl_str_mv Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
title Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
spellingShingle Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
Leon,Rogéria M.
immunosuppression
risk factors
kidney transplantation
papillomavirus infections
title_short Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
title_full Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
title_fullStr Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
title_full_unstemmed Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
title_sort Immunosuppression and the occurrence of HPV in kidney transplant patients verified by urinary cytology
author Leon,Rogéria M.
author_facet Leon,Rogéria M.
Ranzi,Alana D.
Fardin,Graziele S.
Keitel,Elizete
Brackmann,Rosicler Luzia
Prolla,João Carlos
Bica,Claudia G.
author_role author
author2 Ranzi,Alana D.
Fardin,Graziele S.
Keitel,Elizete
Brackmann,Rosicler Luzia
Prolla,João Carlos
Bica,Claudia G.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Leon,Rogéria M.
Ranzi,Alana D.
Fardin,Graziele S.
Keitel,Elizete
Brackmann,Rosicler Luzia
Prolla,João Carlos
Bica,Claudia G.
dc.subject.por.fl_str_mv immunosuppression
risk factors
kidney transplantation
papillomavirus infections
topic immunosuppression
risk factors
kidney transplantation
papillomavirus infections
description ABSTRACT Introduction: Human papillomavirus (HPV) is the main cause of cervical cancer, and immunosuppression is recognized as a risk factor for HPV infection and its persistence. After renal transplantation, immunosuppressive agents are used to prevent rejection, but predispose recipients to chronic infections and malignancies. Objective: This study aimed to verify, based on urinary cytology (UC), the prevalence of HPV in immunosuppressed kidney transplant patients. Material and method: In this cross-sectional study, the population was composed of kidney transplant patients that had undergone routine UC from August 2012 to August 2014. Results: There were 2,305 urine cytopathological tests. Thirteen patients with presence of koilocytes in such examination were observed. Therefore, the relative frequency of patients with HPV detected in urine was 0.56%. In the interval until the first post-transplant year, 10 (76.92%) patients presented koilocytes (p < 0.0001) in the UC. The dosages of immunosuppressive agents until the first post-transplant consultation, which showed correlation with the period between transplantation and the first UC test with the presence of koilocytes (p < 0.0001), were prednisone 10.5-20 mg/day, mycophenolate sodium 901-1,440 mg/day, and tacrolimus 4.5-12 mg/day. Conclusion: This study showed immunosuppression as an important risk factor for infection by HPV or its reactivation. Screening UC tests after transplantation may evidence HPV infection.
publishDate 2016
dc.date.none.fl_str_mv 2016-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000100025
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442016000100025
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1676-2444.20160009
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv
Sociedade Brasileira de Patologia Clínica
publisher.none.fl_str_mv
Sociedade Brasileira de Patologia Clínica
dc.source.none.fl_str_mv Jornal Brasileiro de Patologia e Medicina Laboratorial v.52 n.1 2016
reponame:Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
instname:Sociedade Brasileira de Patologia (SBP)
instacron:SBP
instname_str Sociedade Brasileira de Patologia (SBP)
instacron_str SBP
institution SBP
reponame_str Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
collection Jornal Brasileiro de Patologia e Medicina Laboratorial (Online)
repository.name.fl_str_mv Jornal Brasileiro de Patologia e Medicina Laboratorial (Online) - Sociedade Brasileira de Patologia (SBP)
repository.mail.fl_str_mv ||jbpml@sbpc.org.br
_version_ 1752122296357617664